跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMVANEX SUSPENSION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IMVANEX SUSPENSION INYECTABLE
Approved
STANDARD
IMVANEX SUSPENSION INYECTABLE
Bavarian Nordic A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 14, 2024
Approval ID
4a0a0b129566c41e
Company
Bavarian Nordic A/S
Type
Standard
Approval Details
Approval Id
4a0a0b129566c41e
Drug Cima Aemps Name
IMVANEX SUSPENSION INYECTABLE
Register Number
113855001
Holder Company Name
Bavarian Nordic A/S
Marketing Company Name
Bavarian Nordic A/S
Holder Company Detail Path
/organization/bavarian-nordic-a-s
Marketing Company Detail Path
/organization/bavarian-nordic-a-s
Authorization Date
2024-06-14
Dosage Form
SUSPENSIÓN INYECTABLE
Dose
5 x 10e7 U.Inf
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Bavarian Nordic A/S
Company Detail Path
/organization/bavarian-nordic-a-s
Company Information
Pharmaceutical Company Name
Bavarian Nordic A/S
Country Name
Denmark
City Name
hellerup,hovedstaden,country_dk
Address
Philip Heymans Alle 3
Website
http://www.bavarian-nordic.com
Active Ingredients
VIRUS VIVO MODIFICADO DE LA VIRUELA VACUNOIDE ANKARA
5 x 10e7 unidades infecciosas (Inf.U)
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 14, 2024
Approval ID
4a0a0b129566c41e
Type
Standard
Back to CIMA-AEMPS Approvals